Inventor · disambiguated record
Nagarajan Muthukaman
Also filed as: MUTHUKAMAN NAGARAJAN
9 granted patents·2 pending applications·17 citations·filing 2006–2023
83Inventor score
Top patents by PatentIndex Score
11 records- 0186US9096545B2Triazolone compounds as mPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Aug 4, 2015·7 cites·36 claims
- 0285US9439890B2Triazolone compounds as mPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2015·Granted Sep 13, 2016·4 cites·21 claims
- 0382US10821100B2Triazolone compounds as mPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2019·Granted Nov 3, 2020·1 cites·8 claims
- 0480US9949955B2Triazolone compounds as mPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted Apr 24, 2018·2 cites·12 claims
- 0577US10391083B2Triazolone compounds as MPGES-1 inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Granted Aug 27, 2019·1 cites·14 claims
- 0670US12240808B2Process for the synthesis of calebin-a and its intermediatesMAJEED MUHAMMED·Filed 2022·Granted Mar 4, 2025·0 cites·6 claims
- 0765US2023286893A1Vanillylidenechloroacetone and its use thereof in synthesis of calebin-aMAJEED MUHAMMED·Filed 2023·Application pending·0 cites
- 0862US8519149B2Tricyclic compounds as mPGES-1 inhibitorsGHARAT LAXMIKANT A·Filed 2011·Granted Aug 27, 2013·2 cites·33 claims
- 0959US10457649B2Polymorphs of a mPGES-1 inhibiting triazolone compoundGLENMARK PHARMACEUTICALS SA·Filed 2018·Granted Oct 29, 2019·0 cites·8 claims
- 1054US10112914B2Polymorphs of a mPGES-1 inhibiting triazolone compoundGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted Oct 30, 2018·0 cites·10 claims
- 1127US2008009535A1Inhibitors of phosphodiesterase type-IVBALACHANDRAN SARALA·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nagarajan Muthukaman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →